logo
15:59 Feb 25

Alivus Life Sciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
907.55
+23.95 (+2.71%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Alivus Life Sciences Ltd. Financials

Alivus Life Sciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
907.55
+23.95 (+2.71%)
15:59 Feb 25
Quality
image/svg+xml

57/100
High Financial Strength

Valuation
image/svg+xml

40/100
Mid Valuation

Technical

36/100
Technically Neutral

Strength

8

Weakness

6

Opportunity

0

Threats

0

17.23 %

ROE %

14.23 %

ROA %

44.30

EPS

229.92

BVPS

0.00 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
1885.16 2123.21 2161.22 2283.21 2386.88
Operating Expenses +
1294.09 1507.15 1518.93 1608.97 1704.3
Raw Material
976.2 1001.56 1098.52 1058.58 1053.5
Increase Decrease in Cost
-70.7 41.32 -84.44 -56.57 27.35
Other Manufacturing Expense
1.82 2.66 2.48 3.17 2.43
Employee Cost
149.13 168.72 180.18 258.16 251.7
Miscellaneous Expenses
237.64 292.89 322.19 345.63 369.32
Operating Profit
591.07 616.06 642.29 674.24 682.58
Other Income
0.81 14.7 28.96 12.04 34.57
Depreciation
33.39 37.88 42.09 53.45 60.61
Interest
87.55 27.96 0.55 1.55 2.41
Profit before tax and exceptio..
470.94 564.92 628.61 631.29 654.13
Exceptional Items
0 0 0 0 0
PBT
470.94 564.92 628.61 631.29 654.13
Provision for Taxation
119.36 146.2 161.65 160.4 168.5
Net Profit
351.58 418.72 466.96 470.89 485.63
NET Profit after MI
0 0 0 0 0
EPS
32.61 35.63 38.11 38.43 39.63
Operating Profit Margin (%)
31.35 29.02 29.72 29.53 28.6
Net Profit Margin (%)
18.65 19.72 21.61 20.62 20.35

Alivus Life Sciences Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 74.90 74.90 74.90 75.00 75.00 75.00
FII 5.10 6.80 6.40 6.60 6.70 7.80
Public 7.10 5.50 5.60 5.20 4.90 4.20
Others 12.90 12.80 13.10 13.20 13.40 13.00
Shareholder Shares Holding %
Research 360 logo
Download Our App On: